01 1Auro Peptides Limited
01 1ICATIBANT ACETATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-06-19
Pay. Date : 2019-04-02
DMF Number : 33750
Submission : 2019-04-03
Status : Active
Type : II
20
Auro Peptides Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ICATIBANT ACETATE, with a corresponding US DMF Number 33750.
Remarkably, this DMF maintains an Active status since its submission on April 03, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 19, 2019, and payment made on April 02, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
